Carnegie Mellon and Yale Study in Mice Shows Promise for Treating Genetic Conditions During Early Stages of Development
Researchers at Carnegie Mellon University and Yale University have for the first time used a gene editing technique to successfully cure a genetic condition in utero in a mouse model. Their findings, published in Nature Communications, present a promising new avenue for research into treating genetic conditions during fetal development.
An estimated 8 million children are born each year with severe genetic disorders or birth defects. Genetic conditions can often be detected during pregnancy using amniocentesis, but there are no treatment options to correct these genetic conditions before birth.
“Early in embryonic development, there are a lot of stem cells dividing at a rapid pace. If we can go in and correct a genetic mutation early on, we could dramatically reduce the impact the mutation has on fetal development or even cure the condition,” said Danith Ly, professor of chemistry in Carnegie Mellon’s Mellon College of Science.
In this study, the researchers used a peptide nucleic acid-based gene editing technique that they had previously used to cure beta thalassemia, a genetic blood disorder that results in the reduced production of hemoglobin, in adult mice.
Peptide nucleic acids are synthetic molecules that combine a synthetic protein backbone with the nucleobases found in DNA and RNA. The PNAs used in this study were created by Ly at Carnegie Mellon’s Center for Nucleic Acids Science and Technology (CNAST), a leading center for PNA science.
Their technique uses an FDA-approved nanoparticle to deliver PNA molecules paired with donor DNA to the site of a genetic mutation. When the PNA-DNA complex identifies a designated mutation, the PNA molecule binds to the DNA and unzips its two strands. The donor DNA binds with the faulty DNA and spurs the cell’s DNA repair pathways into action, allowing it to correct the error.
In the current study, the researchers used a technique similar to amniocentesis to inject the PNA complex into the amniotic fluid of pregnant mice whose fetuses carried a mutation in the beta-globin gene that causes beta thalassemia.
With just one injection of the PNA during gestation, the researchers were able to correct 6 percent of the mutations. This 6 percent correction was enough to cause dramatic improvements in the mice’s symptoms of beta thalassemia – and enough for the mice to be considered cured. Mice that were treated using PNA while in utero had levels of hemoglobin that were within the normal range, less spleen enlargement and increased survival rates.
The researchers also noted that there were no off-target effects from the treatment, a finding that might suggest this method would be preferable over other gene editing techniques like CRISPR/Cas9, which can erroneously damage off-target DNA.
“CRISPR is much easier to use, which makes it ideal for laboratory research. But the off-site errors make it less useful for therapeutics,” said Ly. “The PNA technique is more ideal for therapeutics. It doesn’t cut the DNA, it just binds to it and repairs things that seem unusual. We looked at 50 million samples and couldn’t find one offsite error when we used our PNA gene editing technique.”
The researchers believe that their technique might be able to achieve even higher success rates if they can administer it multiple times during gestation. They also hope to see if their technique can be applied to other conditions .
The Latest on: Curing a genetic condition in utero
[google_news title=”” keyword=”Curing a genetic condition in utero” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Curing a genetic condition in utero
- Pro-life states consider abortion exceptions in cases of fatal fetal anomalieson February 25, 2024 at 5:00 am
The obvious truth is that abortion is not a cure or treatment for ... to take a stand for babies in the womb who are believed to have a life-limiting condition and their families," he said.
- Malaria 'cure' in genetic quirkon February 1, 2024 at 4:00 pm
A genetic quirk in an island race could lead to a cure for malaria in two years, it has been claimed. The mutation, which protects people of Papua New Guinea from the disease, has been found by ...
- CRISPR gene therapy seems to cure dangerous inflammatory conditionon January 30, 2024 at 4:00 pm
Nine people with a rare genetic condition that causes life-threatening ... “This is potentially a cure,” says Padmalal Gurugama at Cambridge University Hospitals in the UK, who worked on ...
- The most common genetic conditions in the worldon January 29, 2024 at 7:18 am
Sometimes, though, there's simply nothing to be done to avoid certain conditions ... to 5,000 newborn boys are born with the genetic mutation. No cure for DMD has yet been developed, nor has ...
- Scientists set to cure genetic heart conditions within 'a few years'on July 29, 2022 at 3:23 am
Scientists have said they are just a few years away from curing genetic heart conditions that cause sudden death. These conditions affect around 260,000 people in the UK, so an international team ...
- Genetic Fixes and Future Generationson November 21, 2021 at 3:29 pm
The goal of gene therapy is to cure disease or ailments by permanently repairing problems caused by flaws in our genes. For example, gene therapy could potentially be used to "fix" a genetic flaw ...
- A New Test Can Read Your Future Child's Genome While They're Still in the Wombon February 9, 2018 at 7:53 am
In fact, by using the parents' genomes, researchers have been able to construct a complete genetic ... condition that can be remedied or mitigated before birth or very soon after. Experimental in ...
- DNA Editing May Be Able to Cure Genetic Disorderson May 8, 2017 at 6:13 am
Researchers from the Salk Institute have demonstrated the ability to edit the DNA of cells that do not divide or modify their DNA, partially restoring sight in mice born with genetic defects.
- New Prenatal Genetic Testing Could Predict Your Babyon August 2, 2016 at 2:20 pm
Beginning in the 1970s, amniocentesis allowed doctors to identify genetic disorders in utero, typically mid-pregnancy. Within the following decade, CVS provided an alternative to amniocentesis ...
- £1m to find cure for genetic conditionon February 14, 2014 at 4:00 pm
RESEARCHERS from Scotland and the US have been awarded funding to study techniques which could one day lead to them reversing the effects of a debilitating genetic disease. Scientists from Glasgow ...
via Bing News